Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 252
8
Diseases
7
Unique genes
0.330
Avg. similarity score
Abnormality of the skin
Most-connected disease (6 links)
Disease
Searched: Abnormality of the genital system
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Abnormality of the genital system
Abnormality of the skin
Cataract 44, hypotrichosis 14
Cataract-alopecia-sclerodactyly syndrome
Alopecia-intellectual disability syndrome
Perniola krajewska carnevale syndrome
Alopecia
Amr syndrome
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Abnormality of the skin | 6 | 6 | 1 |
| Cataract 44, hypotrichosis 14 | 6 | 6 | 1 |
| Cataract-alopecia-sclerodactyly syndrome | 6 | 6 | 1 |
| Alopecia-intellectual disability syndrome | 5 | 5 | 2 |
| Perniola krajewska carnevale syndrome | 5 | 5 | 3 |
| Abnormality of the genital system | 3 | 3 | 2 |
| Alopecia | 3 | 3 | 4 |
| Amr syndrome | 2 | 2 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| LSS | 7 / 8 | Abnormality of the genital system, Abnormality of the skin, Alopecia, Alopecia-intellectual disability syndrome and 3 more |
| AHSG | 3 / 8 | Alopecia-intellectual disability syndrome, Amr syndrome, Perniola krajewska carnevale syndrome |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
None of these pathways reaches significance (all FDR q ≥ 0.05). They’re the best candidates found, but treat them as weak evidence for why this cluster groups together.
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Elastic fibre formation | Reactome | 1 / 18 | 95.3× | 1.04e-2 | 5.84e-2 |
| Steroid biosynthesis | KEGG | 1 / 20 | 85.8× | 1.16e-2 | 6.22e-2 |
| Cholesterol biosynthesis | Reactome | 1 / 21 | 81.7× | 1.22e-2 | 6.41e-2 |
| Molecules associated with elastic fibres | Reactome | 1 / 38 | 45.2× | 2.19e-2 | 9.03e-2 |
| Activation of gene expression by SREBF (SREBP) | Reactome | 1 / 42 | 40.9× | 2.42e-2 | 9.58e-2 |
| ECM proteoglycans | Reactome | 1 / 51 | 33.6× | 2.94e-2 | 1.07e-1 |
| Renin secretion | KEGG | 1 / 69 | 24.9× | 3.95e-2 | 1.26e-1 |
| Degradation of the extracellular matrix | Reactome | 1 / 70 | 24.5× | 4.01e-2 | 1.28e-1 |
| Integrin cell surface interactions | Reactome | 1 / 81 | 21.2× | 4.63e-2 | 1.38e-1 |
| Arrhythmogenic right ventricular cardiomyopathy | KEGG | 1 / 86 | 20.0× | 4.91e-2 | 1.43e-1 |
| ECM-receptor interaction | KEGG | 1 / 89 | 19.3× | 5.07e-2 | 1.46e-1 |
| Hypertrophic cardiomyopathy | KEGG | 1 / 99 | 17.3× | 5.63e-2 | 1.55e-1 |
| Dilated cardiomyopathy | KEGG | 1 / 105 | 16.3× | 5.96e-2 | 1.60e-1 |
| Peptide ligand-binding receptors | Reactome | 1 / 106 | 16.2× | 6.02e-2 | 1.61e-1 |
| Post-translational protein phosphorylation | Reactome | 1 / 108 | 15.9× | 6.13e-2 | 1.63e-1 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| triterpenoid biosynthetic process | GO:0016104 | 1 / 1 | 2,670× | 3.75e-4 | 7.81e-3 ✓ sig. |
| regulation of protein localization to cell leading edge | GO:1905871 | 1 / 1 | 2,670× | 3.75e-4 | 7.81e-3 ✓ sig. |
| response to wounding | GO:0009611 | 2 / 81 | 65.9× | 3.84e-4 | 7.95e-3 ✓ sig. |
| cellular response to human chorionic gonadotropin stimulus | GO:0044751 | 1 / 2 | 1,335× | 7.49e-4 | 1.23e-2 ✓ sig. |
| transforming growth factor beta production | GO:0071604 | 1 / 2 | 1,335× | 7.49e-4 | 1.23e-2 ✓ sig. |
| podocyte apoptotic process | GO:1903210 | 1 / 2 | 1,335× | 7.49e-4 | 1.23e-2 ✓ sig. |
| cardiac chamber formation | GO:0003207 | 1 / 3 | 890× | 1.12e-3 | 1.55e-2 ✓ sig. |
| semaphorin-plexin signaling pathway involved in axon guidance | GO:1902287 | 1 / 3 | 890× | 1.12e-3 | 1.55e-2 ✓ sig. |
| endothelin receptor signaling pathway involved in heart process | GO:0086101 | 1 / 3 | 890× | 1.12e-3 | 1.55e-2 ✓ sig. |
| pinocytosis | GO:0006907 | 1 / 4 | 667× | 1.50e-3 | 1.82e-2 ✓ sig. |
| renal albumin absorption | GO:0097018 | 1 / 4 | 667× | 1.50e-3 | 1.82e-2 ✓ sig. |
| Langerhans cell differentiation | GO:0061520 | 1 / 4 | 667× | 1.50e-3 | 1.82e-2 ✓ sig. |
| atrial cardiac muscle tissue development | GO:0003228 | 1 / 4 | 667× | 1.50e-3 | 1.82e-2 ✓ sig. |
| sympathetic neuron axon guidance | GO:0097492 | 1 / 4 | 667× | 1.50e-3 | 1.82e-2 ✓ sig. |
| neural crest cell fate commitment | GO:0014034 | 1 / 4 | 667× | 1.50e-3 | 1.82e-2 ✓ sig. |